Evaluation of partial least-squares with second-order advantage for the multi-way spectroscopic analysis of complex biological samples in the presence of analyte–background interactions
Literature Information
María J. Culzoni, Héctor C. Goicoechea, Ariana P. Pagani, Miguel A. Cabezón, Alejandro C. Olivieri
The combination of unfolded partial least-squares (U-PLS) with residual bilinearization (RBL) has not been properly exploited to process experimental second-order spectroscopic information, although it is able to achieve the important second-order advantage. Among other desirable properties, the technique can handle incomplete calibration information, i.e., when only certain analyte concentrations are known in the training set. It can also cope with analyte spectral changes from sample to sample, due to its latent variable structure. In this work, U-PLS/RBL has been successfully applied to experimental fluorescence excitation–emission matrix data aimed at the quantitation of analytes in complex samples: these were the antibiotic tetracycline and the anti-inflammatory salicylate, in both cases in the presence of human serum, where significant analyte–background interactions occur. The interactions of the analyte with the serum proteins modify their spectral fluorescence properties, making it necessary to employ training sets of samples where the biological background is present, possibly causing analyte spectral changes from sample to sample. The predictive ability of the studied model has been compared with that of parallel factor analysis (PARAFAC), as regards test samples containing different sera, and also other pharmaceuticals which could act as potential interferents.
Related Literature
Elucidation of structure and nature of the PdO–Pd transformation using in situ PDF and XAS techniques
Jonathan Keating, Gopinathan Sankar, Timothy I. Hyde, Shinji Kohara, Koji Ohara
DOI: 10.1039/C3CP50600B
Structure of Nb2O5–NaPO3 glasses by X-ray and neutron diffraction
U. Hoppe, L. Delevoye, L. Montagne, M. v. Zimmermann, A. C. Hannon
DOI: 10.1039/C2CP42772A
Powder crystallography of pharmaceutical materials by combined crystal structure prediction and solid-state 1H NMR spectroscopy
Maria Baias, Cory M. Widdifield, Jean-Nicolas Dumez, Hugh P. G. Thompson, Timothy G. Cooper, Elodie Salager, Sirena Bassil, Robin S. Stein, Anne Lesage, Graeme M. Day, Lyndon Emsley
DOI: 10.1039/C3CP41095A
Speciation of adsorbed CO2 on metal oxides by a new 2-dimensional approach: 2D infrared inversion spectroscopy (2D IRIS)
Sergey Sirotin, Philippe Bazin, Françoise Maugé, Arnaud Travert
DOI: 10.1039/C3CP51146D
Assessment of density functional methods with correct asymptotic behavior
Chen-Wei Tsai, Yu-Chuan Su, Guan-De Li
DOI: 10.1039/C3CP50441G
Field effect transistors and RC filters from pencil-trace on paper
Narendra Kurra, Dipanwita Dutta, Giridhar U. Kulkarni
DOI: 10.1039/C3CP50675D
Chronoamperometric study of membrane electrode assembly operation in continuous flow photoelectrochemical water splitting
Jan Rongé, Dorien Nijs, Stef Kerkhofs, Kasper Masschaele, Johan A. Martens
DOI: 10.1039/C3CP50890K
A time resolved high energy X-ray diffraction study of cooling liquid SiO2
C. J. Benmore, M. C. Wilding, S. K. Tumber
DOI: 10.1039/C3CP44347G
New Li2FeSiO4–carbon monoliths with controlled macropores: effects of pore properties on electrode performance
George Hasegawa, Mai Sannohe, Yuya Ishihara, Kazuyoshi Kanamori, Kazuki Nakanishi, Takeshi Abe
DOI: 10.1039/C3CP50352F
You might also like
How should waste containing (6-Bromo-2-naphthyl)oxy](dimethyl)(2-methyl-2-propanyl)silane be handled?
Waste containing (6-Bromo-2-naphthyl)oxy](dimethyl)(2-methyl-2-propanyl)silane (...
How is 7-Fluoro-4-isoquinolinecarboxylic acid (CAS: 1841081-40-0) typically synthesized?
7-Fluoro-4-isoquinolinecarboxylic acid can be synthesized via a multi-step proce...
What are the physical and chemical properties of 2,3,5,6-Tetrabromothieno[3,2-b]thiophene (CAS: 124638-53-5)?
2,3,5,6-Tetrabromothieno[3,2-b]thiophene is a crystalline compound with a high m...
Is 1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide (CAS: 1542705-92-9) safe?
1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indol...
What is the market or research trend for imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3-methyl-4-oxo- (CAS: 113942-30-6)?
The market for imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3...
What is 3-(Triisopropylsilyl)propiolaldehyde (CAS: 163271-80-5)?
3-(Triisopropylsilyl)propiolaldehyde is a synthetic organic compound with the CA...
What regulatory guidelines apply to 6-Nitro-2H-1,4-benzoxazin-3(4H)-one (CAS: 81721-87-1)?
6-Nitro-2H-1,4-benzoxazin-3(4H)-one (CAS: 81721-87-1) is subject to various regu...
How should waste containing (3-Fluorophenyl)(4-{[(2-methyl-2-propanyl)oxy]carbonyl}-1-piperazinyl)acetic acid (CAS: 885272-91-3) be handled?
Waste containing (3-Fluorophenyl)(4-{[(2-methyl-2-propanyl)oxy]carbonyl}-1-piper...
What are the physical and chemical properties of N,N'-4,4'-Biphenyldiyldiisonicotinamide (CAS: 55119-40-9)?
N,N'-4,4'-Biphenyldiyldiisonicotinamide is a white crystalline solid with a mole...
What industries use 6-Bromo-8-fluoro-2-quinazolinol (CAS: 1036756-15-6)?
6-Bromo-8-fluoro-2-quinazolinol is primarily used in the pharmaceutical industry...
Source Journal
Analyst

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.














